Advertisement

Topics

NuCana plc: NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update

16:05 EST 27 Nov 2018 | FinanzNachrichten

Favorable Data Presented at ESMO on NUC-1031 (Acelarin) and NUC-3373 First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer Initiation of Phase III Study of Acelarin in...

Original Article: NuCana plc: NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update

NEXT ARTICLE

More From BioPortfolio on "NuCana plc: NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...